Insider: Russell Alan J Chief Scientific Officer - Edgewise Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 23,400 | 0 | 23,400 |
| Value | $354,627.00 | $0.00 | $354,627.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/26/2025 | DDS | 100,000 | Direct | COM | $14.60 | $1,459,760.00 | 23,400 |
| 08/12/2025 | DDS | 1,907 | Direct | COM | $13.39 | $25,539.31 | 23,400 |
| 05/02/2025 | DDS | 1,551 | Direct | COM | $16.45 | $25,520.46 | 18,521 |
| 03/07/2025 | DDS | 200 | Direct | COM | $30.02 | $6,004.00 | 14,863 |
| 02/06/2025 | DDS | 1,200 | Direct | COM | $30.13 | $36,153.00 | 14,863 |
| 02/05/2025 | DDS | 8,015 | Direct | COM | $30.02 | $240,623.12 | 14,863 |
| 12/30/2024 | DDS | 100,000 | Direct | COM | $27.37 | $2,737,470.00 | 14,863 |
| 09/20/2024 | DDS | 74,185 | Direct | COM | $28.25 | $2,096,052.66 | 13,534 |
| 09/20/2024 | DDS | 815 | Direct | COM | $29.51 | $24,048.53 | 12,719 |
| 05/02/2024 | DDS | 1,576 | Direct | COM | $18.91 | $29,802.16 | 7,238 |
| 12/26/2023 | DDS | 172,585 | Direct | COM | $9.33 | $1,610,097.24 | 3,606 |
| 05/02/2023 | DDS | 1,602 | Direct | COM | $8.90 | $14,265.65 | 176,191 |
| 11/15/2021 | DDS | 441 | Direct | COM | $19.07 | $8,410.22 | 38 |
| 11/15/2021 | DDS | 38 | Direct | COM | $19.61 | $745.18 | 0 |
| 11/12/2021 | DDS | 8,562 | Direct | COM | $19.51 | $167,073.73 | 479 |
| 11/11/2021 | DDS | 15,595 | Direct | COM | $19.82 | $309,043.00 | 12,722 |
| 11/11/2021 | DDS | 3,681 | Direct | COM | $20.43 | $75,195.47 | 9,041 |
| 11/10/2021 | DDS | 11,746 | Direct | COM | $19.70 | $231,446.71 | 28,897 |
| 11/10/2021 | DDS | 580 | Direct | COM | $20.21 | $11,723.08 | 28,317 |
| 11/09/2021 | DDS | 16,864 | Direct | COM | $19.94 | $336,274.91 | 53,355 |
| 11/09/2021 | DDS | 12,712 | Direct | COM | $20.30 | $258,030.72 | 40,643 |
| 11/08/2021 | DDS | 9,017 | Direct | COM | $20.16 | $181,824.20 | 70,219 |
| 11/05/2021 | DDS | 6 | Direct | COM | $20.70 | $124.20 | 92,272 |
| 11/05/2021 | DDS | 13,036 | Direct | COM | $19.62 | $255,783.27 | 79,236 |
| 11/04/2021 | DDS | 7,392 | Direct | COM | $19.76 | $146,091.79 | 92,278 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research